Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Andrew Pospisilik

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Cellular and Molecular Life Sciences : CMLS|March 12, 2013
Metabolism shaping chromatin shaping metabolismJ Andrew Pospisilik
Cellular and Molecular Life Sciences : CMLS|March 7, 2013
Bridging epigenomics and complex disease: the basicsRaffaele Teperino, Adelheid Lempradl, J Andrew Pospisilik
Nature Reviews. Genetics|October 14, 2015
Exploring the emerging complexity in transcriptional regulation of energy homeostasisAdelheid Lempradl, J Andrew Pospisilik, Josef M Penninger
Regulatory Peptides|March 23, 2005
Dipeptidyl peptidase IV inhibitors: how do they work as new antidiabetic agents?Christopher H S McIntosh, Hans-Ulrich Demuth, J Andrew Pospisilik, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Chronic obesity does not alter cancer incidence in <i>Trp53</i> <sup></sup> miceIlaria Panzeri, Zachary Madaj, Luca Fagnocchi, et al.
Journal of Parkinson'S Disease|March 8, 2021
Decreased Risk of Parkinson's Disease After Rheumatoid Arthritis Diagnosis: A Nested Case-Control Study with Matched Cases and ControlsJonas Bacelis, Michele Compagno, Sonia George, et al.
Annals of the New York Academy of Sciences|September 3, 2009
AIF: not just an apoptosis-inducing factorNicholas Joza, J Andrew Pospisilik, Emilie Hangen, et al.
The International Journal of Biochemistry & Cell Biology|January 31, 2006
Applications of dipeptidyl peptidase IV inhibitors in diabetes mellitusChristopher H S McIntosh, Hans-Ulrich Demuth, Su-Jin Kim, et al.
Elife|October 20, 2021
Sequence features of retrotransposons allow for epigenetic variabilityKevin R Costello, Amy Leung, Candi Trac, et al.
Advances in Experimental Medicine and Biology|April 5, 2003
Dipeptidyl peptidase IV inhibition in animal models of diabetesJ Andrew Pospisilik, Jan A Ehses, Timothy Doty, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Cellular and Molecular Life Sciences : CMLS|March 12, 2013
Metabolism shaping chromatin shaping metabolismJ Andrew Pospisilik
Cellular and Molecular Life Sciences : CMLS|March 7, 2013
Bridging epigenomics and complex disease: the basicsRaffaele Teperino, Adelheid Lempradl, J Andrew Pospisilik
Nature Reviews. Genetics|October 14, 2015
Exploring the emerging complexity in transcriptional regulation of energy homeostasisAdelheid Lempradl, J Andrew Pospisilik, Josef M Penninger
Regulatory Peptides|March 23, 2005
Dipeptidyl peptidase IV inhibitors: how do they work as new antidiabetic agents?Christopher H S McIntosh, Hans-Ulrich Demuth, J Andrew Pospisilik, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Chronic obesity does not alter cancer incidence in <i>Trp53</i> <sup></sup> miceIlaria Panzeri, Zachary Madaj, Luca Fagnocchi, et al.
Journal of Parkinson'S Disease|March 8, 2021
Decreased Risk of Parkinson's Disease After Rheumatoid Arthritis Diagnosis: A Nested Case-Control Study with Matched Cases and ControlsJonas Bacelis, Michele Compagno, Sonia George, et al.
Annals of the New York Academy of Sciences|September 3, 2009
AIF: not just an apoptosis-inducing factorNicholas Joza, J Andrew Pospisilik, Emilie Hangen, et al.
The International Journal of Biochemistry & Cell Biology|January 31, 2006
Applications of dipeptidyl peptidase IV inhibitors in diabetes mellitusChristopher H S McIntosh, Hans-Ulrich Demuth, Su-Jin Kim, et al.
Elife|October 20, 2021
Sequence features of retrotransposons allow for epigenetic variabilityKevin R Costello, Amy Leung, Candi Trac, et al.
Advances in Experimental Medicine and Biology|April 5, 2003
Dipeptidyl peptidase IV inhibition in animal models of diabetesJ Andrew Pospisilik, Jan A Ehses, Timothy Doty, et al.
Pageof 6